• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Establishing a prognostic threshold for total copy number variation within adult IDH-mutant grade II/III astrocytomas.

作者信息

Mirchia Kanish, Snuderl Matija, Galbraith Kristyn, Hatanpaa Kimmo J, Walker Jamie M, Richardson Timothy E

机构信息

Department of Pathology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.

Department of Pathology, New York University Langone Health, New York City, NY, 10016, USA.

出版信息

Acta Neuropathol Commun. 2019 Jul 26;7(1):121. doi: 10.1186/s40478-019-0778-3.

DOI:10.1186/s40478-019-0778-3
PMID:31349875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6660955/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6f/6660955/80cc99c3de0c/40478_2019_778_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6f/6660955/80cc99c3de0c/40478_2019_778_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6f/6660955/80cc99c3de0c/40478_2019_778_Fig1_HTML.jpg

相似文献

1
Establishing a prognostic threshold for total copy number variation within adult IDH-mutant grade II/III astrocytomas.确定成人异柠檬酸脱氢酶（IDH）突变的II/III级星形细胞瘤中总拷贝数变异的预后阈值。
Acta Neuropathol Commun. 2019 Jul 26;7(1):121. doi: 10.1186/s40478-019-0778-3.
2
Total copy number variation as a prognostic factor in adult astrocytoma subtypes.总体拷贝数变异作为成人星形细胞瘤亚型的预后因素。
Acta Neuropathol Commun. 2019 Jun 10;7(1):92. doi: 10.1186/s40478-019-0746-y.
3
Targeted copy number analysis outperforms histologic grading in predicting patient survival for WHO grades II/III IDH-mutant astrocytomas.在预测世界卫生组织II/III级异柠檬酸脱氢酶（IDH）突变型星形细胞瘤患者的生存率方面，靶向拷贝数分析优于组织学分级。
Neuro Oncol. 2019 Jun 10;21(6):819-821. doi: 10.1093/neuonc/noz052.
4
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.异柠檬酸脱氢酶（IDH）突变型星形细胞瘤亚组中快速进展为胶质母细胞瘤：全基因组分析
J Neurooncol. 2017 May;133(1):183-192. doi: 10.1007/s11060-017-2431-y. Epub 2017 Apr 18.
5
MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.磁共振成像表型与 IDH 突变型胶质瘤全基因组拷贝数丰度的范围相关。
Neuroradiology. 2019 Sep;61(9):1023-1031. doi: 10.1007/s00234-019-02219-8. Epub 2019 May 27.
6
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.新型改良的 IDH 突变型星形细胞瘤分级系统。
Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.
7
Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.分子特征与染色体不稳定性与 IDH 突变型和 IDH 野生型星形细胞瘤的拷贝数变异模式和患者预后相关。
J Neuropathol Exp Neurol. 2021 Mar 22;80(4):354-365. doi: 10.1093/jnen/nlab008.
8
Mitotic Index Thresholds Do Not Predict Clinical Outcome for IDH-Mutant Astrocytoma.有丝分裂指数阈值不能预测 IDH 突变型星形细胞瘤的临床结局。
J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1002-1010. doi: 10.1093/jnen/nlz082.
9
T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas.T2-FLAIR 错配信号预测 IDH 突变星形细胞瘤中的 DNA 甲基化亚类和 CDKN2A/B 状态。
Clin Cancer Res. 2024 Aug 15;30(16):3512-3519. doi: 10.1158/1078-0432.CCR-24-0311.
10
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas.异柠檬酸脱氢酶突变在接受同源治疗的间变性星形细胞瘤和胶质母细胞瘤患者中的预后作用。
Acta Neuropathol Commun. 2019 Oct 17;7(1):156. doi: 10.1186/s40478-019-0817-0.

引用本文的文献

1
The molecular history of IDH-mutant astrocytomas without adjuvant treatment.未接受辅助治疗的异柠檬酸脱氢酶（IDH）突变型星形细胞瘤的分子史。
Brain Pathol. 2025 Mar;35(2):e13300. doi: 10.1111/bpa.13300. Epub 2024 Oct 30.
2
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.遗传和表观遗传不稳定性是 IDH 突变型星形细胞瘤进展和侵袭性行为的潜在驱动因素。
Acta Neuropathol. 2024 Jul 16;148(1):5. doi: 10.1007/s00401-024-02761-7.
3
T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas.

本文引用的文献

1
Total copy number variation as a prognostic factor in adult astrocytoma subtypes.总体拷贝数变异作为成人星形细胞瘤亚型的预后因素。
Acta Neuropathol Commun. 2019 Jun 10;7(1):92. doi: 10.1186/s40478-019-0746-y.
2
Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.胶质母细胞瘤患者超长生存期的全基因组分析。
J Neuropathol Exp Neurol. 2019 Jun 1;78(6):501-507. doi: 10.1093/jnen/nlz025.
3
Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics.令神经肿瘤学家满意：一种快速进行常规分子胶质瘤诊断的方法。
T2-FLAIR 错配信号预测 IDH 突变星形细胞瘤中的 DNA 甲基化亚类和 CDKN2A/B 状态。
Clin Cancer Res. 2024 Aug 15;30(16):3512-3519. doi: 10.1158/1078-0432.CCR-24-0311.
4
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.DNA 甲基化亚分类、非整倍体和 CDKN2A/B 纯合缺失在预测 IDH 突变星形细胞瘤临床结局中的预后价值。
Neuro Oncol. 2024 Jun 3;26(6):1042-1051. doi: 10.1093/neuonc/noae009.
5
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.遗传改变导致 RB 和 PDGFRA 信号通路失活，从而推动 IDH2 突变星形细胞瘤的肿瘤进展。
Acta Neuropathol Commun. 2023 Nov 27;11(1):186. doi: 10.1186/s40478-023-01683-x.
6
Chromosomal instability in adult-type diffuse gliomas.成人型弥漫性神经胶质瘤中的染色体不稳定性。
Acta Neuropathol Commun. 2022 Aug 17;10(1):115. doi: 10.1186/s40478-022-01420-w.
7
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.CDKN2A/B 纯合缺失在异柠檬酸脱氢酶突变星形细胞瘤中的转化意义。
Neuro Oncol. 2023 Jan 5;25(1):28-36. doi: 10.1093/neuonc/noac205.
8
Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas.全球 DNA 甲基化分析揭示 IDH 突变型星形细胞瘤中的染色体不稳定性。
Acta Neuropathol Commun. 2022 Mar 9;10(1):32. doi: 10.1186/s40478-022-01339-2.
9
Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.根据 2021 年世界卫生组织中枢神经系统肿瘤分类对成人弥漫性胶质瘤进行分级。
Lab Invest. 2022 Feb;102(2):126-133. doi: 10.1038/s41374-021-00667-6. Epub 2021 Sep 9.
10
is a novel independent predictor of prognosis in LGG patients with mutation.是具有 突变的低级别胶质瘤（LGG）患者预后的一种新型独立预测指标。
Open Life Sci. 2021 Apr 8;16(1):323-335. doi: 10.1515/biol-2021-0039. eCollection 2021.
Neuro Oncol. 2018 Nov 12;20(12):1682-1683. doi: 10.1093/neuonc/noy128.
4
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.快速进展型 IDH 突变星形细胞瘤的遗传和表观遗传特征。
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):542-548. doi: 10.1093/jnen/nly026.
5
Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.使用实时纳米孔测序对脑肿瘤进行同日基因组和表观基因组诊断。
Acta Neuropathol. 2017 Nov;134(5):691-703. doi: 10.1007/s00401-017-1743-5. Epub 2017 Jun 21.
6
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.弥漫性胶质瘤的多维尺度分析：在具有预后相关分子亚型发现的 2016 年世界卫生组织分类系统中的应用。
Acta Neuropathol Commun. 2017 May 22;5(1):39. doi: 10.1186/s40478-017-0443-7.
7
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.异柠檬酸脱氢酶（IDH）突变型星形细胞瘤亚组中快速进展为胶质母细胞瘤：全基因组分析
J Neurooncol. 2017 May;133(1):183-192. doi: 10.1007/s11060-017-2431-y. Epub 2017 Apr 18.
8
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类：概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
9
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.分子分析揭示弥漫性胶质瘤的生物学离散亚群和进展途径。
Cell. 2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028.
10
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.弥漫性低级别胶质瘤的综合、整合基因组分析
N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10.